Advanced search
Publication Cover
Hematology Volume 21, 2016 - Issue 7
Submit an article Journal homepage
945
Views
11
CrossRef citations to date
0
Altmetric
Hematological Malignancy

Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials

Richard T. SilverMyeloproliferative Neoplasms Center, Division of Hematology–Oncology, Department of Medicine, Weill Cornell Medical Center, New York, USACorrespondence[email protected]
&
Hans Carl HasselbalchDepartment of Hematology, Roskilde Hospital, University of Copenhagen, Denmark
Pages 387-391 | Published online: 26 Feb 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Richard T Silver & Ghaith Abu-Zeinah. (2023) Polycythemia vera: aspects of its current diagnosis and initial treatment. Expert Review of Hematology 16:4, pages 253-266.
Read now
Mads Emil Bjørn & Hans Carl Hasselbalch. (2017) Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib. Expert Review of Hematology 10:5, pages 393-404.
Read now

Articles from other publishers (9)

Hans Hasselbalch, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine A. Knudsen, Marko Lucijanić & Rajko Kusec. (2022) Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers 14:22, pages 5495.
Crossref
Yingxin Sun, Yifeng Cai, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Qian Wang, Depei Wu & Suning Chen. (2021) Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World. Frontiers in Oncology 11.
Crossref
Hans C. Hasselbalch & Richard T. Silver. (2021) New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms. HemaSphere 5:12, pages e645.
Crossref
Ghaith Abu-Zeinah, Spencer Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, Niamh Savage, Claudia Sosner, Ellen K. Ritchie, Joseph M. Scandura & Richard T. Silver. (2021) Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival. Leukemia 35:9, pages 2592-2601.
Crossref
Veronika Buxhofer‐Ausch, Dominik Wolf, Siegfried Sormann, Ernst Forjan, Wolfgang Schimetta, Bettina Gisslinger, Sonja Heibl, Maria Theresa Krauth, Jürgen Thiele, Reinhard Ruckser & Heinz Gisslinger. (2020) Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia. European Journal of Haematology 106:1, pages 58-63.
Crossref
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Barbara Grohmann-Izay, Hans C Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, Franz Bauer, Nicoleta Berbec, Carlos Besses Raebel, Zita Borbenyi, Horia Bumbea, Veronika Buxhofer-Ausch, Malgorzata Calbecka, Emilie Cayssials-Caylus, Mario Cazzola, Olga Cerna, Andrei Cucuianu, Delia Monica Dima, Ernst Forjan, Emanuil Gheorghita, Richard Greil, Antonia Hatalova, Mikulas Hrubisko, Janos Jakucs, Polina Kaplan, Sergiy Klymenko, Steffen Koschmieder, Mihaela Lazaroiu, Tamila Lysa, Zvenyslava Masliak, Tamas Masszi, Georgi Mihaylov, Alexander Myasnikov, Uwe Platzbecker, Mathieu Puyade, Jerome Rey, Lydia Roy, Jiri Schwarz, Aleksander Skotnicki, Irina Sokolova, Maria Soroka-Wojtaszko, Jolanta Starzak-Gwozdz, Vera Stoeva, Jose Miguel Torregrosa-Diaz, Anna Vallova, Elena Volodicheva, Krzysztof Warzocha, Ella Willenbacher & Dominik Wolf. (2020) Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. The Lancet Haematology 7:3, pages e196-e208.
Crossref
Elena Crisà, Marco Cerrano, Eloise Beggiato, Giulia Benevolo, Giuseppe Lanzarone, Paola Maria Manzini, Alessandra Borchiellini, Ludovica Riera, Mario Boccadoro & Dario Ferrero. (2017) Can pegylated interferon improve the outcome of polycythemia vera patients?. Journal of Hematology & Oncology 10:1.
Crossref
Richard T. Silver, Ariella C. Barel, Elena Lascu, Ellen K. Ritchie, Gail J. Roboz, Paul J. Christos, Attilio Orazi, Duane C. Hassane, Wayne Tam & Nicholas C. P. Cross. (2017) The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis. Cancer 123:14, pages 2680-2687.
Crossref
R.T. Silver. (2016) Is polycythemia vera curable with recombinant interferon alfa (rIFNα)?. Leukemia Research 44, pages S10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.